Table 1.
Genotype | Tumor formation (n/N) * | Metastasis (n/N) | Median survival (days) |
---|---|---|---|
Apcfl/fl;Ptenfl/fl | 18/18 | 0/18 | 64.5 |
Apcfl/fl;Ptenfl/fl;Arid1afl/+ | 28/28 | 5/28 | 86.5 |
Apcfl/fl;Ptenfl/fl;Arid1afl/fl | 15/15 | 9/15 | 74.5 |
| |||
Euthanized (weeks) | |||
| |||
Apcfl/+;Ptenfl/fl;Arid1afl/fl | 3/8 | 40 | |
Apcfl/fl;Ptenfl/+;Arid1afl/fl | 2/7 | 1/7 | 40 |
Apcfl/fl;Ptenfl/+;Arid1afl/+ | 2/9 | 40 | |
Apcfl/+;Ptenfl/fl;Arid1afl/+ | 2/8 | 1/8 | 40 |
Apcfl/+;Ptenfl/+;Arid1afl/fl | 2/5 | 40 | |
Apcfl/+;Ptenfl/+;Arid1afl/+ | 0/4 | 40 | |
Apcfl/+;Ptenfl/fl | 1/20 | 1/20 | 60 |
Apcfl/fl;Ptenfl/+ | 0/20 | 60 |
n: number of mice that formed tumors or metastases;
N: total number of mice evaluated